8月19日，贝斯美（300796）（300796）发布2025年半年度报告，上半年公司实现营收7.76亿元，同比 增长16.57%；归母净利润3470.64万元，同比增长109.70%；扣非净利润3287.01万元，同比增长 125.95%；基本每股收益0.1元/股，同比增长100.00%。 随着环保农药产业政策持续释放红利，叠加公司在技术研发、品牌积淀等多维度构筑的强劲市场竞争 力，共同构成了贝斯美自产农药业务持续稳健增长的核心动能；子公司捷力克凭借在全球农药流通领域 积累的丰富专业经验、成熟营销网络，以及数量众多的海外农药登记证等先发优势，有力助推公司农药 出海业务拓展，形成了自产与出口协同并进的良好发展格局。同时，公司依托戊酮装置及间戊二烯原材 料预处理技术切入碳五新材料领域，把握高端产品进口替代机遇，构筑差异化壁垒。多板块协同发力， 为贝斯美持续拓展市场空间、实现高质量发展奠定坚实基础。 强链补链筑基，以绿色发展引领农药行业未来 随着农业现代化进程加速与绿色发展理念深化，高效、安全、经济、环境友好的农药新产品推广，已成 为推动农业可持续发展的关键抓手。中研普华产业研究院《"十四五"农药行业发展形势研究 ...

Core Viewpoint - Beishimei (300796) reported strong financial performance for the first half of 2025, with significant increases in revenue and net profit compared to the previous year [1] Financial Performance Summary - Total revenue for the first half of 2025 reached 776 million yuan, a year-on-year increase of 16.57% [1] - Net profit attributable to shareholders was 34.71 million yuan, up 109.7% year-on-year [1] - In Q2 2025, total revenue was 354 million yuan, reflecting a 13.4% increase year-on-year, while net profit for the quarter was 8.72 million yuan, soaring 344.08% year-on-year [1] - Gross margin improved to 18.72%, an increase of 3.3% year-on-year, and net margin rose to 4.42%, up 82.92% year-on-year [1] - Total expenses (selling, administrative, and financial) amounted to 83.89 million yuan, accounting for 10.81% of revenue, a decrease of 6.97% year-on-year [1] Key Financial Metrics - Earnings per share (EPS) doubled to 0.1 yuan, a 100% increase year-on-year [1] - Net asset value per share increased to 4.78 yuan, up 4.28% year-on-year [1] - Operating cash flow per share was -0.06 yuan, a significant decrease of 162.44% year-on-year [1] Changes in Financial Items - Sales expenses increased by 31.42% due to higher salaries for sales personnel and marketing expenses [2] - Financial expenses decreased by 49.8% due to reduced losses [2] - Income tax expenses rose by 45.25%, primarily due to profits from tax-exempt regions and a decrease in deferred tax expenses [2] - Net cash flow from operating activities decreased by 162.44% due to increased cash payments for goods and services [2] - Net cash flow from investing activities increased by 77.29% due to reduced capital expenditures [2] - Net cash flow from financing activities decreased by 61.27% due to increased cash payments for debt repayment [2] Business Model and Investment Considerations - The company's performance is heavily reliant on capital expenditures, necessitating careful evaluation of the profitability of these investments [3] - Historical financial performance indicates a median Return on Invested Capital (ROIC) of 10.08%, with a notably poor ROIC of -0.9% in 2024 [3] - Analysts suggest monitoring the company's cash flow situation, debt levels, and accounts receivable status [4]

Core Viewpoint - The agricultural chemical sector experienced a rise of 1.83% on August 20, with Jiangshan Co., Ltd. leading the gains [1]. Group 1: Market Performance - The Shanghai Composite Index closed at 3766.21, up 1.04% [1]. - The Shenzhen Component Index closed at 11926.74, up 0.89% [1]. Group 2: Individual Stock Performance - Jiangshan Co., Ltd. (600389) closed at 24.66, with a gain of 5.61% and a trading volume of 141,200 shares, amounting to a transaction value of 342 million yuan [1]. - Yuntianhua Co., Ltd. (600096) closed at 26.95, up 5.27%, with a trading volume of 490,900 shares and a transaction value of 1.318 billion yuan [1]. - Xin'an Chemical Industry Co., Ltd. (600596) closed at 10.71, gaining 4.18%, with a trading volume of 461,300 shares and a transaction value of 483 million yuan [1]. - Batian Ecological Engineering Co., Ltd. (002170) closed at 10.49, up 3.96%, with a trading volume of 683,100 shares and a transaction value of 717 million yuan [1]. - Hubei Xuanhua Co., Ltd. (000422) closed at 13.75, gaining 3.38%, with a trading volume of 469,200 shares and a transaction value of 637 million yuan [1]. - Xianda Co., Ltd. (603086) closed at 10.57, up 3.12%, with a trading volume of 851,100 shares and a transaction value of 907 million yuan [1]. - New Agricultural Co., Ltd. (002942) closed at 19.91, gaining 3.00%, with a trading volume of 45,100 shares and a transaction value of 8.86 million yuan [1]. - Stanley Co., Ltd. (002588) closed at 9.63, up 2.77%, with a trading volume of 141,200 shares [1]. - Xingfa Group (600141) closed at 25.83, gaining 2.70%, with a trading volume of 188,300 shares and a transaction value of 484 million yuan [1]. - Runfeng Co., Ltd. (301035) closed at 68.50, up 2.70%, with a trading volume of 13,500 shares and a transaction value of 90.67 million yuan [1]. Group 3: Fund Flow Analysis - The agricultural chemical sector saw a net outflow of 82.02 million yuan from main funds, while speculative funds experienced a net inflow of 277 million yuan, and retail investors had a net outflow of 195 million yuan [2].

Group 1 - The company reported a revenue of 776,132,021.01 yuan for the first half of 2025, representing a year-on-year growth of 16.57% [2] - The net profit attributable to shareholders of the listed company was 34,706,358.19 yuan, showing a significant year-on-year increase of 109.70% [2]

Company Overview - Shaoxing BSM Chemical Co., Ltd. reported a revenue of CNY 776.13 million for the first half of 2025, representing a 16.57% increase compared to CNY 665.83 million in the same period last year [1] - The net profit attributable to shareholders increased by 109.70% to CNY 34.71 million from CNY 16.55 million year-on-year [1] - Basic and diluted earnings per share both doubled to CNY 0.10 from CNY 0.05 [1] Financial Performance - The company experienced a significant decline in net cash flow from operating activities, which was negative CNY 22.33 million, down 162.44% from CNY 35.76 million in the previous year [1] - The total assets at the end of the reporting period were CNY 3.26 billion, a 3.04% increase from CNY 3.16 billion at the end of the previous year [2] - The net assets attributable to shareholders rose to CNY 1.73 billion, reflecting a 1.02% increase from CNY 1.71 billion [2] Shareholder Information - The largest shareholder, Ningbo BSM Investment Holdings Co., Ltd., holds 23.02% of the shares, with 41.33 million shares pledged [3] - Other significant shareholders include Jiangsu Xihua Private Equity Fund Management Co., Ltd. with 5.35% and Wang Qifeng with 3.38% [3] - The report indicates that there were no changes in the controlling shareholder or actual controller during the reporting period [4]

Group 1 - The board meeting of Shaoxing Baismei Chemical Co., Ltd. was held on August 18, 2025, with all 8 directors present, confirming compliance with legal and regulatory requirements [1] - The board approved the 2025 semi-annual report, affirming that it accurately reflects the company's operational status without any misleading statements or omissions [1][2] - The company has adhered to regulations regarding the storage and use of raised funds, ensuring no violations occurred in the management of these funds [2][3] Group 2 - The board approved the extension of the fundraising project timeline, which does not alter the project's implementation, funding purposes, or investment scale, and will not adversely affect the company's operations [3]

Group 1 - The sixth meeting of the fourth supervisory board of Shaoxing Baisimei Chemical Co., Ltd. was held on August 18, 2025, with all six supervisors present, confirming compliance with legal and regulatory requirements [1] - The supervisory board approved the 2025 semi-annual report, stating that it accurately reflects the company's actual situation without any false records or misleading statements [1][2] - The company strictly adhered to relevant regulations regarding the storage and use of raised funds, with all procedures followed correctly, and no violations reported [2] Group 2 - The company decided to postpone some fundraising investment projects based on the usage progress of raised funds and actual operating conditions, ensuring no change in the purpose of the funds or harm to shareholder interests [3] - The postponement of investment projects does not involve related transactions and complies with relevant laws and regulations [3]

证券代码：300796 证券简称：贝斯美 公告编号：2025-065 绍兴贝斯美化工股份有限公司（以下简称"公司"）于2025年8月18日召开了第四 届董事会第九次会议、第四届监事会第六次会议，分别审议通过了《关于公司部分 募投项目延期的议案》，同意公司在募投项目实施主体、实施方式、建设内容、募 集资金投资用途及投资规模不发生变更的前提下，对首发部分募投项目达到预定可 使用状态的时间进行调整，该议案无需提交公司股东大会审议。现将具体情况公告 如下： 一、首发募集资金的基本情况 经中国证券监督管理委员会证监发行字[2019]1783号文核准，公司于2019年11月 向社会公开发行人民币普通股（A股）3,030万股，每股发行价为14.25元，应募集资 金总额为人民币43,177.50万元，根据有关规定扣除发行费用3,879.74万元后，实际募 集资金净额为39,297.76万元。该募集资金已于2019年11月到账。上述资金到账情况 业经容诚会计师事务所会验字[2019]7999号《验资报告》验证。公司对募集资金采 取了专户存储管理。 绍兴贝斯美化工股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、 ...

根据《深圳证券交易所上市公司自律监管指引第2号—创业板上市公司规范运作》 《深圳证券交易所创业板上市公司自律监管指南第1号—业务办理》《企业会计准则》以 及公司关于会计政策的相关规定，绍兴贝斯美化工股份有限公司（以下简称"公司 "） 为真实、准确、客观反映公司的财务状况和经营成果，根据《企业会计准则》相关规定， 本着谨慎性原则，对合并财务报表范围内的各项需要计提减值的资产进行了评估和分析， 对预计可能发生减值损失的相关资产计提减值准备。根据《深圳证券交易所上市公司自 律监管指引第2号—创业板上市公司规范运作》等法律法规的规定，本次计提减值准备无 需提交董事会或股东大会审议，现将具体情况公告如下： 一、本次计提减值准备的情况 （一）本次计提减值准备的原因 证券代码：300796 证券简称：贝斯美 公告编号：2025-064 绍兴贝斯美化工股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或者重大遗漏。 （三）计提资产减值准备的具体说明 根据《企业会计准则第22号金融工具确认和计量》 以及公司会计政策，公 司应收款项、其他应收款以预期信用损失为基础确认信用减值损失， ...

Group 1 - The report details the non-operating fund occupation and related transactions of Shaoxing Baisimei Chemical Co., Ltd. for the first half of 2025, including amounts and reasons for fund occupation [1] - The total non-operating fund occupation at the end of June 2025 amounts to 323,363,046.32 yuan, with significant contributions from related parties [1] - The company has recorded a total of 267,369,206.32 yuan in receivables from its subsidiary Tongling Baisimei Technology Co., Ltd. as of June 2025 [1] Group 2 - The report indicates that the company has engaged in non-operating transactions with its subsidiaries, including a loan of 25,000,000 yuan from Tongling Baisimei Technology Co., Ltd. [1] - Another subsidiary, Ningbo Baisimei New Materials Technology Co., Ltd., has a receivable balance of 18,000,000 yuan as of June 2025, reflecting ongoing financial interactions [1] - The report was approved by the board of directors on August 18, 2025, indicating compliance with corporate governance standards [1]